logo

IMA

ImageneBio·NASDAQ
--
--(--)
--
--(--)
3.59 / 10
Netural

Financial analysis yields subpar rating (3.6/10). Positive contributors: PB-ROE and Profit-MV, whereas limitations surface in Revenue-MV and Gross profit margin (%). Concluding evaluation: guarded.

Fundamental(3.59)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score1/3
Weight10.55%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight9.27%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score1/3
Weight-0.81%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight15.80%
1M Return7.79%
PB-ROE
Value1.40
Score3/3
Weight24.81%
1M Return11.47%
Current assets turnover ratio
Value0.01
Score2/3
Weight1.85%
1M Return1.15%
Fixed assets turnover ratio
Value1.12
Score3/3
Weight1.35%
1M Return0.86%
Asset-MV
Value-0.50
Score1/3
Weight19.15%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight15.82%
1M Return7.73%
Net profit / Total profit (%)
Value99.81
Score2/3
Weight2.23%
1M Return1.28%
Is IMA fundamentally strong?
  • IMA scores 3.59/10 on fundamentals and holds a Fair valuation at present. Backed by its -65.78% ROE, 0.00% net margin, -1.43 P/E ratio, 0.55 P/B ratio, and 87.13% earnings growth, these metrics solidify its Netural investment rating.